OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study
Carlo Torti, Pier Paolo Olimpieri, Paolo Bonfanti, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100684-100684
Open Access | Times Cited: 10
Carlo Torti, Pier Paolo Olimpieri, Paolo Bonfanti, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100684-100684
Open Access | Times Cited: 10
Showing 10 citing articles:
Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study
Sandra Rajme‐López, Bernardo Alfonso Martínez-Guerra, Carla Marina Román-Montes, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 2
Sandra Rajme‐López, Bernardo Alfonso Martínez-Guerra, Carla Marina Román-Montes, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 2
Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis
Maria Mazzitelli, Alberto Enrico Maraolo, Claudia Cozzolino, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Maria Mazzitelli, Alberto Enrico Maraolo, Claudia Cozzolino, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Tracking SARS-CoV-2 RNA in the Air: Lessons from a COVID-19 Outbreak in an Infirmary Unit
Shuk‐Ching Wong, Jonathan Hon-Kwan Chen, Pui Hing Chau, et al.
American Journal of Infection Control (2024)
Closed Access | Times Cited: 2
Shuk‐Ching Wong, Jonathan Hon-Kwan Chen, Pui Hing Chau, et al.
American Journal of Infection Control (2024)
Closed Access | Times Cited: 2
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
The Lancet Regional Health - Europe (2024) Vol. 41, pp. 100912-100912
Open Access | Times Cited: 1
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
The Lancet Regional Health - Europe (2024) Vol. 41, pp. 100912-100912
Open Access | Times Cited: 1
Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence
Ioannis Karniadakis, Nikolaos Mazonakis, Constantinos Tsioutis, et al.
Infectious Disease Reports (2023) Vol. 15, Iss. 6, pp. 662-678
Open Access | Times Cited: 4
Ioannis Karniadakis, Nikolaos Mazonakis, Constantinos Tsioutis, et al.
Infectious Disease Reports (2023) Vol. 15, Iss. 6, pp. 662-678
Open Access | Times Cited: 4
Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data
Andrea De Vito, Agnese Colpani, Giordano Madeddu
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100694-100694
Open Access | Times Cited: 2
Andrea De Vito, Agnese Colpani, Giordano Madeddu
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100694-100694
Open Access | Times Cited: 2
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care?
Enrico Maria Trecarichi, Vincenzo Olivadese, Chiara Davoli, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access
Enrico Maria Trecarichi, Vincenzo Olivadese, Chiara Davoli, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study
Gian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa, et al.
HemaSphere (2024) Vol. 8, Iss. 10
Open Access
Gian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa, et al.
HemaSphere (2024) Vol. 8, Iss. 10
Open Access
Impact of oral early antiviral therapies for mild–moderate COVID-19 in the outpatient’s setting during Omicron era: a pharmacoeconomic analysis
Vincenzo Scaglione, Samuele Gardin, Lolita Sasset, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Vincenzo Scaglione, Samuele Gardin, Lolita Sasset, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Nirmatrelvir/ritonavir for COVID-19: an overview of systematic reviews
Mario Cruciani, Ilaria Pati, Francesca Masiello, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 79, Iss. 3, pp. 477-497
Closed Access | Times Cited: 1
Mario Cruciani, Ilaria Pati, Francesca Masiello, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 79, Iss. 3, pp. 477-497
Closed Access | Times Cited: 1
